BioMarin Pharmaceutical
BMRN
#2013
Rank
ยฃ7.57 B
Marketcap
ยฃ39.20
Share price
-0.34%
Change (1 day)
-8.84%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): ยฃ0.28 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are ยฃ3.24 Billion. In 2025 the company made an earning of ยฃ0.35 Billion a decrease over its 2024 earnings that were of ยฃ0.40 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ0.28 B-20.92%
2025 ยฃ0.35 B-10.94%
2024 ยฃ0.40 B187.31%
2023 ยฃ0.14 B26.07%
2022 ยฃ0.11 B-298.51%
2021 -ยฃ56.05 Million78.04%
2020 -ยฃ31.49 Million-55.36%
2019 -ยฃ70.53 Million-33.56%
2018 -ยฃ0.11 Billion297.78%
2017 -ยฃ26.69 Million-95.68%
2016 -ยฃ0.62 Billion437.12%
2015 -ยฃ0.12 Billion23.91%
2014 -ยฃ92.89 Million-29.25%
2013 -ยฃ0.14 Billion49.23%
2012 -ยฃ87.99 Million171.11%
2011 -ยฃ32.46 Million103.01%
2010 -ยฃ15.99 Million-3903.54%
2009 ยฃ0.42 M-98.31%
2008 ยฃ24.86 M-189.7%
2007 -ยฃ27.72 Million51.02%
2006 -ยฃ18.36 Million-61.58%
2005 -ยฃ47.77 Million-56.59%
2004 -ยฃ0.12 Billion95.13%
2003 -ยฃ56.39 Million12.09%
2002 -ยฃ50.31 Million73.19%
2001 -ยฃ29.05 Million18.32%
2000 -ยฃ24.55 Million19.65%
1999 -ยฃ20.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
ยฃ5.69 B 1,886.15%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ0.4 Billion-239.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ81.11 Million-128.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ20.42 Million-107.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ0.14 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ0.21 B-26.47%๐Ÿ‡บ๐Ÿ‡ธ USA